Quadrant Capital Group’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-487
| Closed | -$7.49K | – | 2742 |
|
|
2025
Q4 | $7.49K | Sell |
487
-312
| -39% | -$3.44K | ﹤0.01% | 2277 |
|
|
2025
Q3 | $7.93K | Buy |
+799
| New | +$8.32K | ﹤0.01% | 2224 |
|
|
2025
Q2 | – | Sell |
-5,402
| Closed | -$70.1K | – | 1707 |
|
|
2025
Q1 | $70.1K | Hold |
5,402
| – | – | ﹤0.01% | 1618 |
|
|
2024
Q4 | $69K | Buy |
5,402
+604
| +13% | +$7.31K | ﹤0.01% | 1247 |
|
|
2024
Q3 | $53.5K | Buy |
4,798
+2,066
| +76% | +$22.8K | ﹤0.01% | 1414 |
|
|
2024
Q2 | $30.7K | Buy |
2,732
+2,248
| +464% | +$26.2K | ﹤0.01% | 1666 |
|
|
2024
Q1 | $6.01K | Buy |
484
+35
| +8% | +$457 | ﹤0.01% | 2263 |
|
|
2023
Q4 | $6.28K | Hold |
449
| – | – | ﹤0.01% | 2209 |
|
|
2023
Q3 | $6.63K | Hold |
449
| – | – | ﹤0.01% | 2098 |
|
|
2023
Q2 | $5.8K | Buy |
449
+39
| +10% | +$444 | ﹤0.01% | 2171 |
|
|
2023
Q1 | $4.02K | Buy |
410
+15
| +4% | +$160 | ﹤0.01% | 2277 |
|
|
2022
Q4 | $4.2K | Hold |
395
| – | – | ﹤0.01% | 2242 |
|
|
2022
Q3 | $4K | Buy |
395
+21
| +6% | +$274 | ﹤0.01% | 2195 |
|
|
2022
Q2 | $5K | Buy |
374
+29
| +8% | +$308 | ﹤0.01% | 1953 |
|
|
2022
Q1 | $4K | Hold |
345
| – | – | ﹤0.01% | 1963 |
|
|
2021
Q4 | $5K | Hold |
345
| – | – | ﹤0.01% | 1860 |
|
|
2021
Q3 | $7K | Hold |
345
| – | – | ﹤0.01% | 1742 |
|
|
2021
Q2 | $3K | Hold |
345
| – | – | ﹤0.01% | 1986 |
|
|
2021
Q1 | $3K | Hold |
345
| – | – | ﹤0.01% | 1942 |
|
|
2020
Q4 | $2K | Buy |
+345
| New | +$1.56K | ﹤0.01% | 1930 |
|
Other funds holding DVAX
Quadrant Capital Group's DVAX Position: Q1 2026 in Review
Quadrant Capital Group sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 487 shares — an estimated $7.49K sold.
Quadrant Capital Group first reported a position in DVAX in Q4 2020 and held it in 20 quarters. The position peaked at $70.1K in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Quadrant Capital Group reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Quadrant Capital Group sold 487 Dynavax Technologies shares in Q1 2026, an estimated $7.49K.
- Quadrant Capital Group first reported a position in Dynavax Technologies in Q4 2020 and held it in 20 quarters.
- Quadrant Capital Group's Dynavax Technologies position peaked at $70.1K in Q1 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.